And hence the conundrum. Either support or forfeit the stock as the alternative is existential uncertainty?
In the near term, PRY is likely to be the only stakeholder that can withstand long term threats and provide alternatives to existing resources. Another bind here; it suits PRY in near term for continuing stock price uncertainty, it keeps mop-up bid costs low.
As a minority, your only clear avenues for passing judgement on long term performance are to sell your stock or hold and vote with disapproval. Discussing any concerns with management are likely to prove fruitless.
Difficult to compete with the interests of preferential doctor partner stakeholders, particularly when Board dominance remains.
Vote and send message. In the long term you can pressure the management team to expand the resource base such that the power of individual medical resources is diluted, enabling shareholder capital to find its rightful place in this vehicle.
VEI Price at posting:
71.0¢ Sentiment: None Disclosure: Not Held
